# Protein kinase-related tumors in the pediatric population: Updated review on an emerging group with emphasis on the more rarely involved kinases

**Authors:** Uta Flucke, Yvonne M. H. Versleijen-Jonkers, Thomas Mentzel, Annette M. Mueller, Laura S. Hiemcke-Jiwa, Rita Alaggio

PMC · DOI: 10.1007/s00292-026-01537-y · Pathologie (Heidelberg, Germany) · 2026-01-28

## TL;DR

This paper reviews protein kinase-related tumors in children, emphasizing molecular classification over traditional methods to improve diagnosis and treatment.

## Contribution

The paper highlights rare protein kinases involved in pediatric tumors and advocates for molecular stratification in diagnosis.

## Key findings

- Molecular techniques reveal overlapping mesenchymal lesions linked to protein kinases.
- Molecular classification is more clinically relevant than morphological classification for these tumors.
- Rare kinases like RAF proteins are involved in activating similar oncogenic pathways.

## Abstract

Advanced and widespread molecular techniques have deepened our understanding of mesenchymal lesions, revealing considerable overlap among morphologically defined entities now known to be related to protein kinases (PKs). This paradigm shift is important for understanding oncogenesis and also in terms of treatment options and prognosis. Therefore, it is preferable to stratify these tumors molecularly instead of morphologically, as the different categories have clinical implications. Molecular analyses are an essential and integrated part of the diagnostic workup of tissue specimens, especially those of young patients. Involved PKs range from receptor tyrosine kinases (neurotrophic tyrosine receptor kinase [NTRK]1, 2, 3; anaplastic lymphoma kinase [ALK]; proto-oncogene 1 [ROS1]; proto-oncogene [RET]; and proto-oncogene/hepatocyte growth factor receptor [MET]; etc.) to intracytoplasmic serine/threonine kinases (RAF proteins) activating the same pathways. Morphological patterns vary from infantile fibrosarcoma(-like) to lipofibromatosis(-like), dermatofibrosarcoma protuberans(-like), and malignant peripheral nerve sheath tumor-like. However, there is considerable overlap histopathologically and immunohistochemically. Most of the neoplasms are (myo)fibroblastic in type, consisting of monomorphic cells. A hemangiopericytoma-like vasculature can be a diagnostic clue. The immunophenotype is characterized by variable expression of smooth muscle actin (SMA)/desmin/CD34 or CD34/S100. This review provides updates to understand the currently known spectrum of PK-related lesions, with emphasis on those occurring more rarely, to aid proper diagnoses and treatment. The aim is to contribute to a better holistic classification.

## Linked entities

- **Genes:** NTRK1 (neurotrophic receptor tyrosine kinase 1) [NCBI Gene 4914], NTRK2 (neurotrophic receptor tyrosine kinase 2) [NCBI Gene 4915], NTRK3 (neurotrophic receptor tyrosine kinase 3) [NCBI Gene 4916], ALK (ALK receptor tyrosine kinase) [NCBI Gene 238], ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098], RET (ret proto-oncogene) [NCBI Gene 5979], MET (MET proto-oncogene, receptor tyrosine kinase) [NCBI Gene 4233], ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882]
- **Proteins:** SMN1 (survival of motor neuron 1, telomeric), LOC101066771 (desmin-like), CD34 (CD34 molecule), S100A1 (S100 calcium binding protein A1)
- **Diseases:** infantile fibrosarcoma (MONDO:0004557), lipofibromatosis (MONDO:0980767), dermatofibrosarcoma protuberans (MONDO:0011934), malignant peripheral nerve sheath tumor (MONDO:0004345), hemangiopericytoma (MONDO:0005094)

## Full-text entities

- **Genes:** RET (ret proto-oncogene) [NCBI Gene 5979] {aka CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1}, MET (MET proto-oncogene, receptor tyrosine kinase) [NCBI Gene 4233] {aka AUTS9, DA11, DFNB97, HGFR, RCCP2, c-Met}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098] {aka MCF3, ROS, c-ros-1}, CD34 (CD34 molecule) [NCBI Gene 947], ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}
- **Diseases:** infantile fibrosarcoma (MESH:D005354), hemangiopericytoma (MESH:D006393), malignant peripheral nerve sheath tumor (MESH:D018319), dermatofibrosarcoma protuberans (MESH:D018223), mesenchymal lesions (MESH:C535700), neoplasms (MESH:D009369), PK (MESH:C564858)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945949/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945949/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945949/full.md

---
Source: https://tomesphere.com/paper/PMC12945949